Back to results
US 11,446,341 B2Granted
Method for the identification of bacteria
AssigneeGenome Research Limited
InventorsTrevor D. Lawley, Simon Clare, Gordon Dougan
Life of this patent
Estimating the term…
Abstract
A method, for the identification of bacterial isolates suitable for use in bacteriotherapy, the method comprising: (i) preparing a suspension of material collected from a host harbouring microbiota; (ii) addition of an activator of bacterial spores sufficient to allow growth of bacteria from spores present in the suspension; (iii) culturing the suspension; and (iv) identification of at least one bacterial species within the culture.
Claims13
A method, for the identification of bacterial isolates suitable for use in bacteriotherapy in a human recipient, the method comprising:
- (i) preparing a culture of material collected from a host harbouring microbiota;
- (ii) detecting group of individual bacterial species within the culture of step (i) by genomic DNA sequencing, and isolating the group of detected individual bacterial species from the culture;
- (iii) assessing combinations of the group of isolated detected individual species from step (ii) to identify combinations of no more than 9 of the detected individual bacterial species for use in, or suitable for use in, bacteriotherapy by:
- (a) administering the combinations of the group of isolated detected individual bacterial species to a human or non-human animal recipient and measuring a shift in the recipient's microbiota to that of a healthy microbiota, wherein an increase in species diversity indicates a shift to healthy microbiota, and/or
- (b) assessing the combinations of the group of isolated detected individual bacterial species in an animal model to identify combinations that are able to alter host biology such as to resolve a pathology in vivo by altering resident intestinal microbiota composition;
- and
- (iv) selecting a combination of no more than 9 of the isolated detected individual bacterial species assessed in step (iii) that shifts the recipient's microbiota to that of a healthy microbiota by increasing species diversity, and/or resolves a pathology in vivo, for use in bacteriotherapy.
4 more elements
Dependencies are inferred from the claim text.